Ulas Ozkurede

Ulas Ozkurede

Auto-generated profile, based on publicly available information

Ulas Ozkurede

Department of Integrative Biology and Physiology, University of Minnesota, Minneapolis, MN, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2025 in The Journal of Physiology
Verified
Journal Article
Open access
EREmily Rozich
Emily Rozich
UOUlas Ozkurede
Ulas Ozkurede
SPShanmugasundaram Pakkiriswami
Shanmugasundaram Pakkiriswami
RGRyan Gemilere
Ryan Gemilere
SASamira M. Azarin
Samira M. Azarin
JLJulia C. Liu
Julia C. Liu
Ischaemia–reperfusion injury (IRI) is a major cause of cardiomyocyte damage and death from myocardial infarction. Oxidative stress, dysregulated calcium (Ca2+) handling and disrupted mitochondrial dynamics are all key factors in IRI and can play a role in cell death. Mitochondria are a primary source of oxidative stress, which is generated by electron leak from the respiratory chain complexes and the oxidation of accumulated succinate upon reperfusion. The mitochondrial permeability transition pore (mPTP), a high conductance channel that forms following reperfusion of ischaemic mitochondria, has been implicated in reperfusion‐induced cell death. Although factors including mitochondrial Ca2+ overload and oxidative stress that regulate mPTP opening have been well characterized, the composition of the mPTP is still actively investigated. Clinically, mPTP opening and IRI complicate treatment of myocardial infarction. Therefore, many possible therapeutics to reduce the damaging effects of reperfusion are under investigation. Antioxidants, pharmaceutical approaches, postconditioning and synthetic polymers have all been investigated for use in IRI. Still, many of these therapeutics of interest have shown mixed evidence underlying their use in preclinical and clinical research. In this review we discuss our current understanding of the contributions of mitochondrial oxidative stress, mitochondrial Ca2+ and mitochondrial dynamics to cardiomyocyte damage and death in IRI, and where further clarification of these mechanisms is needed to identify potential therapeutic targets. image

18 August 2019 in Aging Cell
Verified
Journal Article
Open access
PDF file
UOUlas Ozkurede
Ulas Ozkurede
RMRichard A. Miller
Richard A. Miller
Prolonged lifespan and improved health in late adulthood can be achieved by partial inhibition of mitochondrial proteins in yeast, worms, fruit flies, and mice. Upregulation of the mitochondrial unfolded protein response (mtUPR) has been proposed as a common pathway in lifespan extension induced by mitochondrial defects. However, it is not known whether mtUPR is elevated in long‐lived mouse models. Here, we report that Snell dwarf mice, which show 30%–40% lifespan extension and prolonged healthspan, exhibit augmented mitochondrial stress responses. Cultured cells from Snell mice show elevated levels of the mitochondrial chaperone HSP60 and mitochondrial protease LONP1, two components of the mtUPR. In response to mitochondrial stress, the increase in Tfam (mitochondrial transcription factor A), a regulator of mitochondrial transcription, is higher in Snell cells, while Pgc‐1α, the main regulator of mitochondrial biogenesis, is upregulated only in Snell cells. Consistent with these differences, Snell cells maintain oxidative respiration rate, ATP content, and expression of mitochondrial‐DNA‐encoded genes after exposure to doxycycline stress. In vivo, compared to normal mice, Snell mice show stronger hepatic mtUPR induction and maintain mitochondrial protein stoichiometry after mitochondrial stress exposure. Overall, our work demonstrates that a long‐lived mouse model exhibits improved mitochondrial stress response, and provides a rationale for future mouse lifespan studies involving compounds that induce mtUPR. Further research on mitochondrial homeostasis in long‐lived mice may facilitate development of interventions that blunt mitochondrial deterioration in neurodegenerative diseases such as Alzheimer's and Parkinson's and postpone diseases of aging in humans.

24 October 2025 in Circulation Research
Verified
Journal Article
Closed access
SPShanmugasundaram Pakkiriswami
Shanmugasundaram Pakkiriswami
JSJae Hwi Sung
Jae Hwi Sung
KSKshama R. Shah
Kshama R. Shah
UÖUlaş Özkurede
Ulaş Özkurede
MSMegan K. Sumera
Megan K. Sumera
JLJulia C. Liu
Julia C. Liu
BACKGROUND: Mitochondrial ATP production, essential for cardiomyocyte function, is regulated by mitochondrial Ca 2+ (mtCa 2+ ). The primary route for mtCa 2+ influx is the mitochondrial calcium uniporter complex. The mitochondrial calcium uniporter complex subunit MICU (mitochondrial calcium uptake) 1 limits mtCa 2+ uptake, preventing mtCa 2+ overload. Although elevated mtCa 2+ has been observed in multiple diseases including heart failure, its effects on heart function remain elusive. METHODS: To investigate the impact of elevated mtCa 2+ in adult hearts, we generated a mouse model with cardiomyocyte-specific tamoxifen-inducible Micu1 deletion ( Micu1 cKO ). Cardiac function was assessed through echocardiography. Mitochondria, adult cardiomyocytes, and tissue extracts were isolated from the left ventricle (LV) and right ventricle (RV) for comprehensive analysis at multiple time points ranging from 1 to 9 weeks post-tamoxifen injection. RESULTS: Acute MICU1 deficiency resulted in increased mtCa 2+ accompanied by reduced mitochondrial respiration in both the RV and LV. Contractile function, which was diminished in both ventricles initially, remained reduced in the RV upon prolonged MICU1 deficiency. In contrast, the LV exhibited signs of recovery over time, including restored ejection fraction concurrent with normalization of mtCa 2+ levels. This pattern was mirrored in cardiomyocyte contractility. In Micu1 cKO RV, mtCa 2+ remained elevated, likely contributing to oxidative stress. As a potential mechanism underlying LV-specific recovery, EMRE (essential MCU [mitochondrial calcium uniporter] regulator), an mitochondrial calcium uniporter complex subunit that promotes mtCa 2+ uptake, was found to be downregulated only in the LV. This suggested that the LV initiated a compensatory response to elevated mtCa 2+ , while the RV remained impacted. Supporting this, proteomics analysis indicated a divergent proteomic signature in Micu1 cKO RV. Follow-up experiments suggested enhanced EMRE degradation in Micu1 cKO LV mediated by m-AAA proteases through a PKA (protein kinase A)–regulated mechanism. In MICU1-deficient neonatal cardiomyocytes, pharmacological PKA inhibition was sufficient to decrease EMRE levels. Analysis of LV tissues from patients with dilated cardiomyopathy suggested that this pathway may be relevant in human DCM. CONCLUSIONS: While elevated mtCa 2+ disrupted cardiac function in both ventricles, it induced an LV-specific adaptive response that suppressed mtCa 2+ intake, contributing to the recovery of mitochondrial and cardiac function. The absence of this pathway in the RV has implications for therapeutics targeting RV dysfunction, a key determinant of mortality in heart failure.

14 October 2024 in Trends in Pharmacological Sciences
Verified
Journal Article
Closed access
UOUlas Ozkurede
Ulas Ozkurede
SPShanmugasundaram Pakkiriswami
Shanmugasundaram Pakkiriswami
JLJulia C. Liu
Julia C. Liu

2 November 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
UOUlas Ozkurede
Ulas Ozkurede
SRShreya Rajhans
Shreya Rajhans
FAFederica Accornero
Federica Accornero
JLJulia C. Liu
Julia C. Liu
Summary: Mitochondrial gene expression in mammals requires the processing of polycistronic transcripts into mature RNAs, generating multigene maturation intermediates. Yet these species and their potential association with mitochondrial stress remain poorly characterized. We analyzed intact RNA species in healthy mouse hearts through direct RNA sequencing and identified polyadenylated mitochondrial transcripts containing complete mRNA sequences with uncleaved tRNA extensions, which we termed immature mRNAs (imRNAs). Guided by these findings, we developed a new computational tool to estimate imRNA levels using conventional short-read RNA-seq datasets. Analysis of mouse hearts deficient in mitochondrial superoxide dismutase 2 (SOD2), a model of mitochondrial oxidative stress, revealed selectively elevated levels of imRNAs retaining 5’ tRNA extensions, without increases in those with 3’ tRNA extensions. Comparative analyses of several mouse models with defects in mitochondrial respiration, transcription, translation, or proteostasis did not reproduce this pattern. A mouse model of mitochondrial import stress with reduced ROS generation exhibited decreased levels of imRNAs retaining 5’ tRNA extensions. Conversely, human induced pluripotent stem cells treated with rotenone, which elevates mitochondrial ROS, showed increased levels of imRNAs retaining 5’ but not 3’ tRNA extensions, reproducing the pattern observed in SOD2-deficient mouse hearts. These findings identify an imRNA signature potentially associated with mitochondrial oxidative stress. The presence of imRNAs described here suggests that widely used transcriptome analysis pipelines may count these species as mature mRNAs, overestimating mitochondrial mRNA levels and overlooking defects in RNA maturation. By enabling retrospective analysis of processing intermediates, our tool provides access to previously unexamined information in existing RNA-seq datasets.